{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:23:51Z","timestamp":1790792631896,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.det.2016.11.002","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T02:20:46Z","timestamp":1489717246000},"page":"117-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo\u00a0Patients"],"prefix":"10.1016","volume":"35","author":[{"given":"Nada","family":"Elbuluk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9988","key":"10.1016\/j.det.2016.11.002_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaad.2015.07.039","article-title":"Vitiligo is not a cosmetic disease","volume":"73","author":"Ezzedine","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jdv.12169","article-title":"Clinical profile of generalized vitiligo patients with associated autoimmune\/autoinflammatory diseases","volume":"28","author":"van Geel","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/0378-6323.32710","article-title":"Srikant. Vitiligo: a part of a systemic autoimmune process","volume":"73","author":"Gopal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"10.1016\/j.det.2016.11.002_bib5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1468-3083.2010.03605.x","article-title":"Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey","volume":"24","author":"Akay","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3349\/ymj.2015.56.3.719","article-title":"Prevalence of vitiligo and associated comorbidities in Korea","volume":"56","author":"Lee","year":"2015","journal-title":"Yonsei Med J"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12166","article-title":"Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms","volume":"168","author":"Gey","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1684\/ejd.2009.0939","article-title":"Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases","volume":"20","author":"Amerio","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cup.12437","article-title":"Colocalization of vitiligo and alopecia areata presenting as poliosis","volume":"42","author":"Walker","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.det.2016.11.002_bib10","doi-asserted-by":"crossref","first-page":"435947","DOI":"10.1155\/2015\/435947","article-title":"The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients","volume":"2015","author":"Saylam Kurtipek","year":"2015","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1203475415610071","article-title":"The relationship between the serum level of vitamin D and vitiligo: a controlled study on 300 subjects","volume":"20","author":"Khurrum","year":"2016","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000247164","article-title":"Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients","volume":"188","author":"Schallreuter","year":"1994","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.5021\/ad.2014.26.6.764","article-title":"Segmental vitiligo and extragenital lichen sclerosus et atrophicus simultaneously occurring on the opposite sides of the abdomen","volume":"26","author":"Lee","year":"2014","journal-title":"Ann Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/120347541201600408","article-title":"Vitiligo and associated autoimmune disease: retrospective review of 300 patients","volume":"16","author":"Sawicki","year":"2012","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000354607","article-title":"Comorbidities associated with vitiligo: a ten-year retrospective study","volume":"227","author":"Sheth","year":"2013","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4103\/2229-5178.142511","article-title":"Coexistence of mucous membrane pemphigoid and vitiligo","volume":"5","author":"Aithal","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000368772","article-title":"Concomitant mycosis fungoides and vitiligo: how mycosis fungoides may contribute to melanocyte destruction","volume":"230","author":"Herrmann","year":"2015","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","article-title":"Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families","volume":"60","author":"Narita","year":"2011","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000357807","article-title":"Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study","volume":"228","author":"Ingordo","year":"2014","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.det.2016.11.002_bib21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/thy.2010.1643","article-title":"Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease","volume":"20","author":"Spritz","year":"2010","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.det.2016.11.002_bib22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/jdv.12870","article-title":"Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan","volume":"29","author":"Chen","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bjd.13276","article-title":"Most individuals with either segmental or nonsegmental vitiligo display evidence of bilateral cochlear dysfunction","volume":"172","author":"Anbar","year":"2015","journal-title":"BR J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0190-9622(81)70051-3","article-title":"The prevalence of vitiligo and polisosis in patients with uveitis","volume":"4","author":"Nordlund","year":"1981","journal-title":"J Am Acadm Dermatol"},{"issue":"11","key":"10.1016\/j.det.2016.11.002_bib26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.autrev.2013.01.004","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"12","author":"Greco","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0378-6323.19730","article-title":"Vitiligo: a sign of systemic disease","volume":"72","author":"Huggins","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.det.2016.11.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr.04.2011.4052","article-title":"Alezzandrini syndrome","volume":"2011","author":"Gupta","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5603\/EP.2014.0044","article-title":"A\u00a0case of autoimmune urticaria accompanying autoimmune polyglandular syndrome type III associated with Hashimoto's disease, type 1 diabetes mellitus, and vitiligo","volume":"65","author":"Kasznicki","year":"2014","journal-title":"Endokrynol Pol"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0974-7753.114705","article-title":"Colocalization of vitiligo and alopecia areata: coincidence or consequence?","volume":"5","author":"Kumar","year":"2013","journal-title":"Int J Trichology"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamadermatol.2014.3324","article-title":"Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis","volume":"151","author":"Mohan","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2016.11.002_bib32","first-page":"15","article-title":"Childhood vitiligo: a retrospective hospital based study, Jeddah, Saudi Arabia","volume":"15","author":"Al-Jabri","year":"2011","journal-title":"JSSDDS"},{"issue":"12","key":"10.1016\/j.det.2016.11.002_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/exd.12264","article-title":"Vitiligo and alopecia areata: apples and oranges?","volume":"22","author":"Harris","year":"2013","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaad.2015.12.049","article-title":"Follicular vitiligo: a report of 8 cases","volume":"74","author":"Gan","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/pcmr.12186","article-title":"Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes","volume":"27","author":"Ezzedine","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"8","key":"10.1016\/j.det.2016.11.002_bib36","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamadermatol.2013.4228","article-title":"Association between vitiligo and atopic disorders: a pilot study","volume":"149","author":"Silverberg","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib37","first-page":"200","article-title":"Vitiligo and autoantibodies of celiac disease","volume":"4","author":"Shahmoradi","year":"2013","journal-title":"Int J Prev Med"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000370303","article-title":"Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet","volume":"6","author":"Khandalavala","year":"2014","journal-title":"Case Rep Dermatol"},{"issue":"11","key":"10.1016\/j.det.2016.11.002_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1726-4901(08)70049-2","article-title":"Dermatitis herpetiformis and vitiligo","volume":"70","author":"Karabudak","year":"2007","journal-title":"J\u00a0Chin Med Assoc"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09674845.2014.11669980","article-title":"Interleukin-6: a possible inflammatory link between vitiligo and type 1 diabetes","volume":"71","author":"Farhan","year":"2014","journal-title":"Br J Biomed Sci"},{"issue":"8","key":"10.1016\/j.det.2016.11.002_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/ijd.12148","article-title":"Prevalence of vitiligo among type 2 diabetic patients in an Iranian population","volume":"53","author":"Afkhami-Ardekani","year":"2014","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3349\/ymj.1999.40.3.195","article-title":"Serum levels of folic acid and vitamin B12 in Korean patients with vitiligo","volume":"40","author":"Kim","year":"1999","journal-title":"Yonsei Med J"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib43","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3906\/sag-1309-87","article-title":"Investigation into the frequency of Helicobacter pylori\u00a0infection with carbon 14 urea breath test in patients with vitiligo","volume":"44","author":"Rifaioglu","year":"2014","journal-title":"Turk J Med Sci"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40257-014-0087-3","article-title":"Relationship between Helicobacter pylori infection and vitiligo: a prospective study","volume":"15","author":"Dogan","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib45","first-page":"169","article-title":"Disseminated vitiligo associated with AIDS","volume":"77","author":"McGowan","year":"2006","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0190-9622(87)70252-7","article-title":"Human immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency?","volume":"17","author":"Duvic","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/0019-5154.164411","article-title":"Acral vitiligo and lichen sclerosus - association or a distinct pattern? A clinical and histopathological review of 15 cases","volume":"60","author":"Attili","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2016.11.002_bib48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.annder.2014.06.019","article-title":"Eosinophilic fasciitis, morphea and vitiligo in a single patient","volume":"141","author":"Lakjiri","year":"2014","journal-title":"Ann Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.det.2016.11.002_bib49","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.4103\/2229-5178.144517","article-title":"Segmental vitiligo with segmental morphea: an autoimmune link?","volume":"5","author":"Yadav","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1203475415615326","article-title":"A\u00a0case of colocalized vitiligo and psoriasis","volume":"20","author":"Langley","year":"2016","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/jdv.12117","article-title":"Non-segmental vitiligo and psoriasis comorbidity - a case-control study in Italian patients","volume":"28","author":"Arunachalam","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2016.11.002_bib52","doi-asserted-by":"crossref","first-page":"e23089","DOI":"10.1371\/journal.pone.0023089","article-title":"Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib53","first-page":"313","article-title":"Association between vitiligo and spondyloarthritis","volume":"28","author":"Padula","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib54","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.4238\/2015.May.25.6","article-title":"Associations between TNF-alpha polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: a meta-analysis","volume":"14","author":"Lee","year":"2015","journal-title":"Genet Mol Res"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5455\/medarh.2013.67.91-93","article-title":"Vitiligo and autoimmunity","volume":"67","author":"Kasumagic-Halilovic","year":"2013","journal-title":"Med Arch"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib56","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"Vrijman","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib57","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4103\/2230-8210.122636","article-title":"Prevalence of thyroid function test abnormalities and thyroid autoantibodies in children with vitiligo","volume":"17","author":"Afsar","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.det.2016.11.002_bib58","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3923\/pjbs.2013.570.574","article-title":"Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population","volume":"16","author":"Nejad","year":"2013","journal-title":"Pak J Biol Sci"},{"key":"10.1016\/j.det.2016.11.002_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000348388","article-title":"High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo","volume":"79","author":"Kroon","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.det.2016.11.002_bib60","doi-asserted-by":"crossref","first-page":"631927","DOI":"10.1155\/2015\/631927","article-title":"Oxidative stress and immune system in vitiligo and thyroid diseases","volume":"2015","author":"Colucci","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.det.2016.11.002_bib61","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.12659\/MSM.894981","article-title":"Pediatric patients with vitiligo in eastern china: abnormalities in 145 cases based on thyroid function tests and immunological findings","volume":"21","author":"Xianfeng","year":"2015","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib62","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1684\/ejd.2014.2396","article-title":"Autoimmune thyroid disease in Italian patients with non-segmental vitiligo","volume":"24","author":"Arunachalam","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamadermatol.2013.927","article-title":"Association between vitiligo extent and distribution and quality-of-life impairment","volume":"149","author":"Silverberg","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2016.11.002_bib64","series-title":"Historical aspects","author":"Gauthier","year":"2010"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0378-6323.107637","article-title":"Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo","volume":"79","author":"Krishna","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib66","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)","volume":"69","author":"Lilly","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/JID.2015.398","article-title":"The vitiligo impact patient scale (VIPs): development and validation of a vitiligo burden assessment tool","volume":"136","author":"Salzes","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib68","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bjd.13839","article-title":"Living with vitiligo: results from a national survey indicate differences between skin phototypes","volume":"173","author":"Ezzedine","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0163-8343(79)90081-1","article-title":"Psychological reaction to chronic skin disorders: a study of patients with vitiligo","volume":"1","author":"Porter","year":"1979","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.det.2016.11.002_bib71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","article-title":"Quality of life in patients with vitiligo","volume":"1","author":"Parsad","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00926230600998482","article-title":"The problems in sexual functions of vitiligo and chronic urticaria patients","volume":"33","author":"Sukan","year":"2007","journal-title":"J\u00a0Sex Marital Ther"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib73","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2005.07050.x","article-title":"Life quality assessment among patients with atopic eczema","volume":"154","author":"Holm","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib74","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/000155500300012873","article-title":"Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity","volume":"80","author":"Lundberg","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2016.11.002_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-4-71","article-title":"The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study","volume":"4","author":"Shikiar","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib76","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1008935921866","article-title":"The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis","volume":"8","author":"Wahl","year":"1999","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib77","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1008944108101","article-title":"Coping and quality of life in patients with psoriasis","volume":"8","author":"Wahl","year":"1999","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib78","first-page":"493","article-title":"Response to cosmetic disfigurement: patients with vitiligo","volume":"39","author":"Porter","year":"1987","journal-title":"Cutis"},{"issue":"7","key":"10.1016\/j.det.2016.11.002_bib79","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2230.2009.03765.x","article-title":"Vitiligo is more than skin deep: a survey of members of the Vitiligo Society","volume":"35","author":"Talsania","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/S0365-05962009000100006","article-title":"Vitiligo and emotions","volume":"84","author":"Nogueira","year":"2009","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib81","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1468-3083.2006.01897.x","article-title":"Stigmatization experience, coping and sense of coherence in vitiligo patients","volume":"21","author":"Schmid-Ott","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2016.11.002_bib82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000350010","article-title":"Cumulative life course impairment in vitiligo","volume":"44","author":"Kruger","year":"2013","journal-title":"Curr Probl Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.002_bib83","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/pde.12226","article-title":"Quality of life impairment in children and adolescents with vitiligo","volume":"31","author":"Silverberg","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.002_bib84","first-page":"83","article-title":"Dermatology life quality index score in vitiligo patients: a pilot study among young Italian males","volume":"147","author":"Ingordo","year":"2012","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2016.11.002_bib85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2133.2008.08788.x","article-title":"Impact of childhood vitiligo on adult life","volume":"159","author":"Linthorst Homan","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.002_bib86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.det.2012.12.010","article-title":"Quality of life in pediatric dermatology","volume":"31","author":"Brown","year":"2013","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib87","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1590\/abd1806-4841.20131915","article-title":"Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders","volume":"88","author":"Manzoni","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.det.2016.11.002_bib88","series-title":"Vitiligo","year":"2010"},{"issue":"Pt 3","key":"10.1016\/j.det.2016.11.002_bib89","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1348\/000711299160077","article-title":"Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy","volume":"72","author":"Papadopoulos","year":"1999","journal-title":"Br J Med Psychol"},{"issue":"9","key":"10.1016\/j.det.2016.11.002_bib90","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archderm.1978.01640210075025","article-title":"Personal responses of patients to vitiligo: the importance of the patient-physician interaction","volume":"114","author":"Porter","year":"1978","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.002_bib91","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","article-title":"Psychiatric morbidity in vitiligo: prevalence and correlates in India","volume":"16","author":"Mattoo","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2016.11.002_bib92","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/bjd.13093","article-title":"Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument","volume":"171","author":"Gupta","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516301292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516301292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:16:53Z","timestamp":1719109013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863516301292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0733863516301292"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2016.11.002","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo\u00a0Patients","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}